Cargando…
Autologous Cord Blood Therapy for Infantile Cerebral Palsy: From Bench to Bedside
About 17 million people worldwide live with cerebral palsy, the most common disability in childhood, with hypoxic-ischemic encephalopathy, preterm birth, and low birth weight being the most important risk factors. This review will focus on recent developments in cell therapy for infantile cerebral p...
Autor principal: | Jensen, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956288/ https://www.ncbi.nlm.nih.gov/pubmed/24695413 http://dx.doi.org/10.1155/2014/976321 |
Ejemplares similares
-
Autologous Cord Blood in Children with Cerebral Palsy: A Review
por: Boruczkowski, Dariusz, et al.
Publicado: (2019) -
Dysfunction of the Blood-brain Barrier in Cerebral Microbleeds: from Bedside to Bench
por: Wang, Hai-ling, et al.
Publicado: (2021) -
Autologous cell-based therapy for treatment of large bone defects: from bench to bedside
por: Verboket, R., et al.
Publicado: (2018) -
CDG Therapies: From Bench to Bedside
por: Brasil, Sandra, et al.
Publicado: (2018) -
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)